Steris (STE) Receivables - Other (2019 - 2020)

Steris (STE) posted Receivables - Other of $9.0 million for Q4 2020, up 4.93% on a QoQ basis from $8.5 million in Q3 2020.

Analysis

Steris (STE) Receivables - Other (2019 - 2020) Analysis & Trends

Steris has reported Receivables - Other for 2 years, with the latest figure at $9.0 million in Q4 2020.

On a quarterly basis, Receivables - Other changed N/A year-over-year to $9.0 million in Q4 2020; TTM through Dec 2020 was $9.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $8.1 million, down 4.97% from the prior year.
Receivables - Other was $9.0 million for Q4 2020 at Steris, up from $8.5 million in the prior quarter.
The five-year high for Receivables - Other was $9.0 million in Q4 2020, with the low at $8.1 million in Q1 2020.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	180.57 Bn	174.97 Bn	7.27 Bn
2	Intuitive Surgical	127.53 Bn	122.31 Bn	1.96 Bn
3	Medtronic	116.86 Bn	108.04 Bn	6.34 Bn
4	Stryker	103.92 Bn	100.44 Bn	4.50 Bn
5	Boston Scientific	63.57 Bn	63.03 Bn	3.85 Bn
6	Edwards Lifesciences	49.82 Bn	45.57 Bn	1.35 Bn
7	Alcon	32.99 Bn	31.53 Bn	1.68 Bn
8	Dexcom	32.16 Bn	30.21 Bn	830.00 Mn
9	Steris	20.64 Bn	20.16 Bn	684.20 Mn
10	Zimmer Biomet Holdings	17.62 Bn	17.21 Bn	1.54 Bn

Historic Data

Download Data